MENU
CVAR
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

CVAR stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Mid-Cap Value
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for CVAR with price predictions
Nov 10, 2026

CVAR in upward trend: price rose above 50-day moving average on October 15, 2026

CVAR moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 41 of 50 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on CVAR as a result. In 68 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The 10-day moving average for CVAR crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 74%.

Following a +1.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVAR advanced for three days, in 183 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 207 of 291 cases where CVAR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Bearish Trend Analysis

The 10-day RSI Indicator for CVAR moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 31 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 72%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 69 cases where CVAR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.

The Moving Average Convergence Divergence Histogram (MACD) for CVAR turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 29 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

CVAR broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), Salesforce (NYSE:CRM), Pfizer (NYSE:PFE), Accenture PLC (NYSE:ACN), Lockheed Martin Corp (NYSE:LMT), Medtronic plc (NYSE:MDT), Newmont Corp (NYSE:NEM), Bristol-Myers Squibb Co (NYSE:BMY), BP plc (NYSE:BP), CVS HEALTH Corp (NYSE:CVS).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange traded fund (“ETF”) that seeks to build a portfolio of approximately 50 to 100 securities across a broad spectrum of market capitalizations and sectors. To achieve its investment objective, it invests primarily in equity securities traded on U.S. exchanges of any size that the fund’s investment adviser, Cultivar Capital, Inc. (the “Adviser”), believes are under-valued, or under-appreciated, by other participants in the broader equity market. The fund is non-diversified.

Market Cap

The average market capitalization across the Cultivar ETF (CVAR) ETF is 66.06B. The market cap for tickers in the group ranges from 160.03M to 353.79B. UNH holds the highest valuation in this group at 353.79B. The lowest valued company is INGN at 160.03M.

High and low price notable news

The average weekly price growth across all stocks in the Cultivar ETF (CVAR) ETF was 13%. For the same ETF, the average monthly price growth was 33%, and the average quarterly price growth was 97%. NEM experienced the highest price growth at 12%, while DOX experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Cultivar ETF (CVAR) ETF was -18%. For the same stocks of the ETF, the average monthly volume growth was -22% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 58
Price Growth Rating: 42
SMR Rating: 59
Profit Risk Rating: 83
Seasonality Score: 21 (-100 ... +100)
CVAR in upward trend: price rose above 50-day moving average on October 15, 2026